Determination of nimodipine in plasma by HPLC-MS/MS and pharmacokinetic application

• Autor(a) principal: Nascimento, Demétrius Fernandes do
• Data de Publicação: 2010
• Outros Autores: Moraes Filho, Manoel Odorico de, Bezerra, Fernando Antônio Frota, Pontes, Andréa Vieira, Uchoa, Célia Regina Amaral, Moraes, Renata Amaral de, Leite, Ismenia Osório, Santana, Gilmara Silva de Melo, Santana, Ana Paula Macedo, Leite, Ana Lourdes Almeida e Silva, Pedrazzoli Júnior, José, Moraes, Maria Elisabete Amaral de
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da Universidade Federal do Ceará (UFC)
• Texto Completo: http://www.repositorio.ufc.br/handle/riufc/17476
• topic: Nimodipino; Farmacocinética

To develop and validate a rapid, specific and highly sensitive method to quantify nimodipine in human plasma using dibucaine as the internal standard (IS). The analyte and IS were extracted from plasma samples by liquid-liquid extraction using hexane-ethyl acetate (1:1 v/v). The chromatographic separation was performed on a Varian ® Polaris C18 analytical column (3 m m, 50 x 2.0 mm) and pre-column Securityguard TM C18 (4.0 x 3.0 mm) with a mobile phase of Acetonitrile-Ammonium acetate 0.02 ml/L (80:20v/v). The method had a chromatographic run time of 4.5 min and linear calibration curve over the range of 0.1- 40 ng/mL (r > 0.9938). The limit of quantification was 100 pg/mL. Acceptable precision and accuracy were obtained for concentrations over the standard curve ranges. This validated method was successfully applied in determining the pharmacokinetic profile of nimodipine tablets of 30 mg administered to 24 healthy volunteers. The proposed method of analysis provided a sensitive and specific assay for nimodipine determination in human plasma. The time for the determination of one plasma sample was 4.5 min. This method is suitable for the analysis of nimodipine in human plasma samples collected for pharmacokinetic, bioavailability or bioequivalence studies in humans.